Cardio-and-Hepatoprotective Benefits of Some Spices in Wistar Rats Induced with Metabolic Syndrome
http://www.doi.org/10.26538/tjnpr/v6i10.25
Keywords:
Heart, Liver,, Metabolic syndrome,, Spices,, Supplemented dietAbstract
The increasing reliance on foods sweetened with fructose is of great concern due to its leading role in development of obesity and other related metabolic disorders. Since oxidative stress is one of the pathogenic processes for development of these disorders, this research evaluated the inclusion of antioxidant-rich spices in diet as means of ameliorating dyslipidaemia and liver dysfunction in metabolic syndrome-induced Wistar rats. Thirty rats were induced with metabolic syndrome using 55.43% high-fructose diet, divided into six groups and fed on diets supplemented with 2 % inclusions of ginger, black pepper, garlic, turmeric and a mixture of the spices. Serum lipid profiles, atherogenic indices and indices of liver function were determined. Compared with the control, metabolic syndrome-induced rats fed the spices-supplemented diets had significantly (p<0.05) higher levels of serum cholesterol, triglyceride and low-density lipoprotein cholesterol which were significantly lower in comparison with the metabolic syndrome-induced rats fed standard diet. The atherogenic index and coronary risk index as well as activities of aspartate aminotransaminase, alanine aminotransaminase, alkaline phosphatase and gamma glutamyl aminotransaminase were significantly (p<0.05) higher in the groups treated with spices-supplemented diets compared with the control, but lower in comparison with the metabolic syndrome-induced rats fed standard diet. There were no significant (p>0.05) variations among groups in levels of serum bilirubin. It is evident that including these spices in diets could alleviate dyslipidaemia and lower serum enzyme activities in metabolic syndrome- induced rats, and could therefore, enhance restoration of heart and liver damages caused by consuming metabolic syndrome-causing diets.
References
Max CP and Gerald IS. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018; 98:2133–2223.
Softic S, Cohen DE, Kahn CR. Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Dig Dis Sci. 2016; 61(5):1282–1293.
Shin-Hae L, Shi-Young P, Cheol SC. Insulin Resistance: From Mechanisms to Therapeutic Strategies. Diabetes Metab J. 2022; 46(1):15-37.
Oguoma VM, Nwose EU, Richards RS. Prevalence of cardio- metabolic syndrome in Nigeria: a systematic review. Pub health. 2015; 129:413-423
Sperling LS, Mechanick JI, Neeland IJ, Herrick CJ, Despres JP, Ndumele CE. The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome. J Am Coll Cardiol. 2015; 66(9):1050–1067.
Lemes IR, Sui X, Fernandes RA, Blair SN, Turi-Lynch BC, Codogno JS, Monteiro HL. Association of sedentary behavior and metabolic syndrome. Public Health. 2019; 167:96-102.
Heontae K and Minsoo K. Sedentary behavior and metabolic syndrome in physically active adults: National Health and Nutrition Examination Survey 2003-2006. Am J Hum Biol. 2019; 8:e23225.
Slagter SN, van Vliet-Ostaptchouk JV, Vonk JM, Boezen HM, Dullaart RP. Associations between smoking, components of metabolic syndrome and lipoprotein particle size. BMC Med. 2013; 11:195.
Aberg F, Helenius-Hietala J, Puuka P, Martti F, Antti J. Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population. Hepatology. 2018; 67(6):2141-2149.
Imam NU, Idoko AS, Osibemhe M, Lawal N, Zaharaddeen AS. Obesity and Insulin Resistance Components of Metabolic Syndrome Induced by High-fructose Diet in Wistar Rats could be attenuated by Spices-Supplemented Diets. J Appld. Sci and Environ Manag. 2022; 26 (5):893-901.
Surapon T. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015; 6(3):456–480
Soleiman M and Jila R. Role of oxidative stress in pathogenesis of metabolic syndrome. Caspian J Intrn Med. 2012; 3(1):386-396
Kaur JA. Comprehensive Review on Metabolic Syndrome. Cardiology Research and Practice. 2014; 943162.
Idoko AS, Abdullahi A, Maibulangu BM, Nura L, Imam NU, Muhammed F, Umar S. Allium sativum and Curcuma longa l Powder Protect Against Hepatotoxic and Nephrotoxic Effects of High-fructose Diet. FUOYE J Pure Appl Sci. 2022; 7(1):59-78.
Ini-Oluwa AA, Stephen AA, Sunday IO, Ganiyu O. Food Biofortification: A Transition from Nutrient Enrichment to Physiological Significance. Trop J Nat Prod Res. 2021; 5(12):2051-2056.
Oluyori AP, Inyinbor AA, Aremu CO, Osemwegie OO, Oluwafemi A, Ogunnupebi TA, Diseases Induced by Heavy Metal Exposure and their Ameliorative Phytochemicals: A Review. Trop J Nat Prod Res. 2020; 4(9):479-489.
Tietz NW. Clinical Guide to Laboratory Tests (2nd ed.). Philadelphia, USA W.B. Sauders Company. 1990.
Abell LL, Levey BB, Brodie BB. Determination of cholesterol in serum and plasma. J Bio Chem. 1952; 195:357.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of low- density lipoprotein cholesterol without the use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502.
Kazemi T, Hajihosseini M, Moossavi M, Hemmati M, Ziaee M. Cardiovascular Risk Factors and Atherogenic Indices in an Iranian Population: Birjand East of Iran. Clin Med Insights Cardiol. 2018. doi: 10.1177/1179546818759286
Schmidt E and Schmidt FW. Determination of serum GOT and GPT. Enzy Biol Chem. 1963; 3:1.
Reitman S and Frankel S. A Colorimetric Method for the Determination of Serum GOT and GPT. American Journal of Clin Pathol. 1957; 28:56-63.
Szasz G. Methods of Enzymatic Analysis. Clin Chem. 1974; 2:715-721.
Recommendations of the Deutsche Gesellschaft für Klinische Chemie (DGKC). J clin chem and clin biochem. 1972; 10:182.
Jendrassik L and Grof P. Serum bilirubin. J Biochem. 1938; 2:297:81.
Taskinen MR, Soderlund S, Bogl LH. Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity. J Intern Med. 2017; 282(2):187- 201.
Samuel VT. Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol Metab. 2011; 22(2):60–65.
Arslan S and Sanlier N. Relationship between daily dietary fructose intake, body composition and biochemical parameters patients with type 2 diabetes. J Hum Sci. 2016; 13(2):2642-2655.
Herman MA and Samuel VT. The sweet path to metabolic demise: fructose and lipid synthesis. Trends Endocrinol Metab. 2016; 27(10):719–730.
Huanqing G, Tao G, Chunli L, Guowei Z, Johji Y, Jianwei W, Yuhao L. Treatment with Ginger Ameliorates Fructose-Induced Fatty Liver and Hypertriglyceridemia in Rats:Modulation of the Hepatic Carbohydrate Response Element-Binding Protein- Mediated Pathway. Evid-Bas Compl and Alter Med. 2012: 570948 10.1155/2012/570948
Tappy L and Lˆe KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010; 90(1):23–46.
Rodr´ıguez-Calvo R, Barroso E, Serrano L. Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A. Hepatology. 2009; 49(1):106–115.
Benhamed F, Denechaud PD, Lemoine M. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J Clin Invest. 2012; 122(6):2176–2194.
Uyeda K and Repa JJ. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab. 2006; 4(2):107–110.
Saravanan G, Ponmurugan P, Deepa MA, Senthilkumar B. Anti- obesity action of gingerol: Effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high-fat diet. J the Sci Food and Agric. 2014; 94(14):2972–2977.
Altobelli E, Angeletti PM, Marziliano C, Mastrodomenico M, Giuliani AR, Petrocelli R. Potential Therapeutic Effects of Curcumin on Glycemic and Lipid Profile in Uncomplicated Type 2 Diabetes-A Meta-Analysis of Randomized Controlled Trial.Nutrients. 2021; 13(2):404.
Panahi Y, Khalili N, Sahebi E, Namazi S, Reiner Ž, Majeed M, Sahebkar A. Curcuminoids Modify Lipid Profile in Type 2 Diabetes Mellitus: A Randomized Controlled Trial. Compl Therap Med. 2017; 33:1–5.
Johnston TP, Korolenko TA, Pirro M, Sahebkar A. Preventing Cardiovascular Heart Disease: Promising Nutraceutical and non- Nutraceutical Treatments for Cholesterol Management. Pharmacol Res. 2017; 120:219–25.
Sahebkar A. Curcuminoids for the Management of Hypertriglyceridaemia. Nat Rev Cardiol. 2014; 11:123.
Si Q, Lifan H, Gong J, Shen S, Juan H, Ren H, Hu H. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutri J. 2017; 16:68.
Nachimuthu M, Magadi GS, Rathinam PS, Ramalingam S, Bhawana B. Curcumin inhibits hyperlipidemia and hepatic fat accumulation in high-fructose-fed male Wistar rats. Pharmaceut Bio. 2016; 54:2857-2863.
Shao W,Yu Z, Chiang Y, Yang Y, Chai T, Foltz W, Lu H, Fantus IG, Jin T. Crcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS One. 2012; 7:e28784.
Sahebkar A, Chew GT, Watts GF. Recent advances in pharmacotherapy for hypertriglyceridemia. Prog Lipid Res. 2014; 56:47–66.
Choi S, Choi Y, Choi Y, Kim S, Jang J, Park T. Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice. Food Chem. 2013; 141(4):3627–35.
Shah SS, Shah GB, Singh SD, Gohil PV, Chauhan K, Shah KA, Chorawala M. Effect of piperine in the regulation of obesity- induced dyslipidemia in high-fat diet rats. Indian J Pharmacol. 2011; 43(3):296–299.
Ramasamy SV, Surya H, Senthilkumar R, Nalini N. Hypolipidemic Effect of Black Pepper (Piper nigrum Linn.) in Rats Fed High Fat Diet. J Clin Biochem Nutc. 2002; 32:31-42.
Vijayakumar RS and Nalini N. Efficacy of piperine, an alkaloidal constituent from Piper nigrum on erythrocyte antioxidant status in high fat diet and antithyroid drug induced hyperlipidemic rats. Cell Biochem and Funct. 2006; 24:6:491-498.
Iciek M, Kwiecień I, Włodek L. Biological properties of garlic and garlic-derived organosulfur compounds. Environ Mol Mutagen. 2009; 50(3):247–265.
El-Bayoumy K, Sinha R, Pinto JT, Rivlin RS. Cancer chemoprevention by garlic and garlic-containing sulfur and selenium compounds. J Nutr. 2006; 136(3):864S–869S
Rai SK, Sharma M, Tiwari M. Inhibitory effect of novel diallyldisulfide analogs on HMG-CoA reductase expression in hypercholesterolemic rats: CREB as a potential upstream target. Life Sci. 2009; 85(5-6):211-219.
Gupta N and Porter TD. Garlic and garlic derived compounds inhibit human squalenemonooxygenase. J Nutr. 2001; 131:1662– 1667.
Abbas M and Ebrahim AO. Effect of garlic on lipid profile and expression of LXR alpha in intestine and liver of hypercholesterolemic mice. J Diabetes Metab Disord. 2014; 13:20.
Aouadi R. Effect of fresh garlic (allium sativum) on lipid metabolism in male rats. Nutr Res. 2000; 20:273–280.
Rodrigues FC, Kumar NA, Thakur G. The Potency of Heterocyclic Curcumin Analogues: An Evidence-Based Review. Pharmacol Res. 2021; 105489.
Dei Cas M and Ghidoni R. Dietary Curcumin: Correlation Between Bioavailability and Health Potential. Nutr. 2019; 11(9):2147.
Jude S, Amalraj A, Kunnumakkara AB, Divya C, Löffler BM, Gopi S. Development of Validated Methods and Quantification of Curcuminoids and Curcumin Metabolites and Their Pharmacokinetic Study of Oral Administration of Complete Natural Turmeric Formulation (Cureit™) in Human Plasma Via UPLC/ESI-Q-TOF-MS Spectrometry. Molecules (Basel Switzerland). 2018; 23(10):2415.
Wu MY, Li CK, Hou MF, Chu PY. New insights into the role of inflammation in the pathogenesis of atherosclerosis. International J Mole Sci. 2017; 18(10):1-18.
Gimbrone MA and Garcia-Cardena G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016; 118(4):620-636.
Poss J, Custodis F, Werner C, Weingärtner O, Böhm M, Laufs U. Cardiovascular disease and dyslipidemia: beyond LDL. Curr Pharm Des. 2011; 17:861–70.
Okamura T. Dyslipidemia and cardiovascular disease: a series of epidemiologic studies in Japanese populations. J Epidemiol. 2010; 20(4):259–65.
Upaganlawar AB and Balaraman R. Cardio protective effect of vitamin E in combination with lycopene on lipid profile, lipid metabolizing enzymes and infarction size in myocardial infarction induced by isoproterenol. Pharmacologia. 2012; 3:215–20.
Vennila L and Pugalendi KV. Efficacy of sesamol on plasma and tissue lipids in isoproterenol-induced cardiotoxicity in wistar rats. Arch Pharma Res. 2012; 8:1465–70.
Idoko AS, Zaharaddeen AS, Ilouno, Ibrahim M, Arinola AM, Dabai TA, Okereke GE. Physical and Biochemical Studies on Excess Weight-Induced Rats Maintained on Mixed Spices- Supplemented Diet. Nigerian J Basic and Appl Sci. 2018; 26(2):09-16.
Crawford JM, Iacobuzio-Donahue C. Liver and biliary tract. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran Pathologic Basis of Disease. 8th ed. Philadelphia, Pennsylvania, USA: Saunders; 2009; 833–90.
Pablo M, Lopez-Sanchez P, Ramos-Tovar E. Fructose and the Liver. Int J Mol Sci. 2021; 22(13):6969.
Prasanthi J and Jean-Pascal D. 2017. Fructose and NAFLD: The Multifaceted Aspects of Fructose. Metabolism Nutrients. 2017; 9:230.
Basaranoglu M, Basaranoglu G, Bugianesi E. Carbohydrate intake and nonalcoholic fatty liver disease: Fructose as a weapon of mass destruction. Hepatobiliary Surg Nutr. 2015; 4:109–116.
Jai SL, Dae WJ, Eun KK, Hye JJ, Ho HN, WKS. Histologic and Metabolic Derangement in High-Fat, High-Fructose, and Combination Diet Animal Models. e Sci World J. 2015; ID 306326.
Xiong ZE, Dong WG, Wang BY, Tong QY, Li ZY. Curcumin attenuates chronic ethanolinduced liver injury by inhibition of oxidative stress via mitogen-activated protein kinase/nuclear factor E2-related factor 2 pathway in mice. Phcog Mag. 2015; 11:707-715.
Salman MMA and Randa RA. Pathophysiological studies on the Reverse Effect of Curcumin (Curcuma longa, Zingiberaceae) and Ursofalk (Ursodeoxycholic acid) against the Toxicity of Carbon Tetrachloride on Albino Rats. J Liver. 2016; 5:3.
Ferramosca A, Di Giacomo M, Zara V. Antioxidant dietaryapproach in treatment of fatty liver: new insights and updates. World J Gastroenterol. 2017; 23:4146–4157.
Egashira K, Sasaki H, Higuchi S, Ieiri I. Food-drug interaction of tacrolimus with pomelo, ginger, and turmeric juice in rats. Drug Metab Pharmacokinet. 2012; 27:242–247.
Inzaugarat ME, De Matteo E, Baz P, Lucero D, García CC,Gonzalez Ballerga E, et al. New evidence for the therapeuticpotential of curcumin to treat nonalcoholic fatty liverdisease in humans. PLoS ONE. 2017; 12:e0172900.
Reyes-Gordillo K, Shah R, Muriel P. Oxidative stress and inflammation in hepatic diseases: current and future therapy. Oxid Med and Cell Longevity. 2017; ID 3140673.
Xiao J, Lv Y, Lin B. A novel antioxidant multitarget iron chelator M30 protects hepatocytes against ethanolinduced injury. Oxid Med and Cell Longevity. 2015; ID 607271.
Afrin R, Arumugam S, Rahman A, Wahed MI,Karuppagounder V, Harima M, Suzuki H,Miyashita S, Suzuki K, Yoneyama H, Ueno K, Watanabe K. Curcumin ameliorates 7liver damage and progression of NASH in NASH-HCC mousemodel possibly by modulating HMGB1-NF-kappaBtranslocation. Int Immunopharmacol. 2017; 44:174–82.
Khan MA, Anwar S, Alijarbou AA. “Protective effect of thymoquinone on glucose or methylglyoxal-induced glycation of superoxide dismutase.” Int J Biol Macromol. 2014; 6516–6520.
Dalila TL, Gleide GF, Julia KDV, Rodrigo BF, Mateus GC, Camilo AC, Virginia RP, Marisa AND. Zingiber officinale formulation reduces hepatic injury and weight gain in rats fed an unhealthy diet. health sciences An Acad Bras Cienc. 2019; 91(4).
Sagita R, Kurniawati E M. Zakiyatul, F. A Systematic Review and Meta-Analysis of Experimental Studies: Can Red Ginger be Used in the Treatment for Women Urinary Tract Infections? Trop J Nat Prod Res. 2022; 6(9):1367-1371.
Badawi M. Histological study of the protective role of ginger on piroxicam-induced liver toxicity in mice. J the Chinese Med Associa. 2018; 1726–4901.
Mohammed AA, Saleh A, Ahmad A, Amjad AK, Shehwaz A, Abdulmajeed GA, Faris A, Arshad HR. 6-Gingerol, a Major Ingredient of Ginger Attenuates Diethylnitrosamine-Induced Liver Injury in Rats through the Modulation of Oxidative Stress and Anti-Inflammatory ActivityMediators of Inflammation. 2021; Article ID 6661937, Doi: 10.1155/2021/6661937
Vipin A, Rao R, Kurrey NK, KA AA, Venkateswaran G. Protective effects of phenolics richextract of ginger against Aflatoxin B1-induced oxidative stress and hepatotoxicity Biomed. Pharmacother. 2017; 91:415-424.
Uhegbu FO, Imo C, Ugbogu AE. Effect of aquous extract of Piper guineense seeds on some liver enzymes, antioxidant enzymes and some hematological parameters in Albino rats. Inter J Plant Sci. 2015; 4:167–171.
El-Halawany AM, El-Dine RS, El-Sayed NS, Hattor IM. Protective effect of Aframomum melegueta phenolics against CCl4-induced rat hepatocytes damage; role of apoptosis and pro- inflammatory cytokines inhibition. Science Reports. 2014; 30:5880.
Vishal D, Hemant P, Lindsay B. Piperine Attenuates Cardiovascular, Liver and Metabolic Changes in High Carbohydrate, High Fat-Fed Rats. Cell Biochem Biophys. 2011: DOI 10.1007/s12013-011-9306-1
Taqvi SI, Shah AJ, Gilani AH. Blood pressure lowering and vasomodulator effects of piperine. J Cardio Pharmacol. 2008; 52:452–458.
Ogbunugafor HA. Physico-chemical and antioxidant properties of Moringa oleifera seed oil. Pakistan J Nutri. 2011; 10:409–414.
Adeyemo A, Ore A, Ajisafe EO. The protective effect of piperine on oxidative stress and hepatic damage induced by diisononyl phthalate in rat. Egypt. j. Basic Appl. Sci. 2021; 8(1).
Amr MA, Ayman S, Mai AZ. The Hepatoprotective Effect of Piperine Against Thioacetamide-Induced Liver Fibrosis in Mice: The Involvement of miR-17 and TGF-β/Smads Pathways. Front Mol Biosci. 2021; 754098, doi: 10.3389/fmolb.2021.754098
Evan PS, Mahima V, Mahaboobkhan R, Kavitha M, Jackline D. Ameliorative Effect of Piperine from Piper Nigrum on D- Galactosamine – Induced Hepatotoxicity in Mice. Int J Pharm Sci. Rev Res. 2013; 21(2):44, 240-245.
Sayan B, Amit K, Nanaocha S, Pallab KH, Pulok KM. Synergistic effect of ursolic acid and piperine in CCl4 induced hepatotoxicity Annals of Med. 2021; 53(1):2009–2017.
Vítek L. Bilirubin as a predictor of diseases of civilization. Is it time to establish decision limits for serum bilirubin concentrations? Arch Biochem Biophys. 2019; 672:108062.
Fevery J. Bilirubin in clinical practice: a review. Liver Int. 2008; 28:592–605.
Nehal M, Bahgat G, Sahar ME, Gehan KM, Rania SM, Marwa SA. Reversion to regular diet with alternate day fasting can cure grade-I non-alcoholic fatty liver disease (NAFLD) in high- fructoseintake- associated metabolic syndrome. Egyptian Liver J. 2021; 11:60.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
